Cargando…
Dermatomyositis as presenting feature of ovarian cancer, treated with neo-adjuvant chemotherapy and interval debulking surgery()
• Dermatomyositis in ovarian cancer responds to treatment with neo-adjuvant carboplatin and paclitaxel in conjunction with corticosteroids. • Recurrence of dermatomyositis symptoms is often the first sign of relapsed disease. • Prognosis of ovarian cancer in context of dermatomyositis is poor.
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier
2013
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3862295/ https://www.ncbi.nlm.nih.gov/pubmed/24371708 http://dx.doi.org/10.1016/j.gynor.2013.07.002 |
| Sumario: | • Dermatomyositis in ovarian cancer responds to treatment with neo-adjuvant carboplatin and paclitaxel in conjunction with corticosteroids. • Recurrence of dermatomyositis symptoms is often the first sign of relapsed disease. • Prognosis of ovarian cancer in context of dermatomyositis is poor. |
|---|